December 15 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday that its CEO Ognyan Donev acquired 200 shares in the company through deals priced at 3.10 levs ($1.94/1.60 euro) per share on December 14.